Will xenotransplantation ever be feasible?

Journal of the American College of Surgeons

Volumn 186, Issue 4, 1998, Pages 383-387

  Starzl, Thomas E ^a,b   Rao, Abdul S ^a   Murase, Noriko ^a   Fung, John ^a   Demetris, Anthomy J ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; NONHUMAN; PRIORITY JOURNAL; SPECIES DIFFERENCE; XENOTRANSPLANTATION;

ANIMALS; FORECASTING; HUMANS; LIVER TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS;

EID: 0031890256     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(98)00053-2     Document Type: Article

References (34)

1. Institute of Medicine. Xenotransplantation: Science, Ethics, and Public Policy. Washington, DC: National Academy Press; 1996.
2. Nuffield Council on Bioethics. Animal to Human Transplants: The Ethics of Xenotransplantation. London: KKS Printing; 1996.
3. Reemtsma K, McCracken BH, Schlegel JU, et al. Renal heterotransplantation in man. Ann Surg 1964;160:384-410.
4. Starzl TE, Marchioro TL, Peters GN, et al. Renal heterotransplantation from baboon to man: experience with 6 cases. Transplantation 1964;2:752-776.
5. Murase N, Starzl TE, Demetris AJ, et al. Hamster-to-rat heart and liverxenotransplantation with FK506 plus antiproliferative drugs. Transplantation 1993;55:701-708.
6. Barker CF, and Billingham RE. Histocompatibility requirements of heart and skin grafts in rats. Transplant Proc 1971;3:172-175.
7. Michaels MG, Lanford R, Demetris AJ, et al. Lack of susceptibility of baboons to infection with hepatitis B virus. Transplantation 1996;61:350-351.
8. Starzl TE, Fung J, Tzakis A, et al. Baboon-to-human liver transplantation. Lancet 1993;341:65-71.
9. Starzl TE, Valdivia LA, Murase N, et al. The biologic basis of and strategies for clinical xenotransplantation. Immunol Rev 1994; 141:213-244.
10. Bailey L, Nehlsen-Cannarella S, Concepcion W, and Jolley W. Baboon to human cardiac xenotransptantation in a neonate. JAMA 1985;254:3321-3329.
11. Valdivia LA, Fung JJ, Demetris AJ, et al. Donor species complement after liver xenotransplantation: mechanism of protection from hyperacute rejection. Transplantation 1994;57:918-922.
12. Starzl TE, and Zinkernagel R. The regulation of immune reactivity by antigen migration and localization: a comparison of "tolerance" to infectious agents and allografts. N Engl J Med, in press, provisional.
13. Zinkernagel RM. Immunology taught by viruses. Science 1996; 271:173-178.
14. Janeway CA, and Travers P. Immunobiology: The Immune System in Health and Disease, 2nd ed., New York: Current Biology Ltd./ Garland Publishing Inc.; 1996.
15. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994;12:991-1045.
16. Galili U, Clark MR, Shohet SB, et al. Evolutionary relationship between the natural anti-Gal antibody and the Gala (1,3) Gal epitope in primates. Proc Natl Acad Sci USA 1987;84:1369-1373.
17. Cooper DKC, Koren E, and Oriol R. Oligosaccharides and discordant xenotransplantation. Immunol Rev 1994;141:31-58.
18. Galili U. Evolution and pathophysiology of the human natural anti-a-galactosyl IgG (anti-Gal) antibody. Springer Semin Immunopathol 1993;15:155-171.
19. White DJG, Oglesbay T, Liszewski MK, et al. Expression of human decay accelerating factor of membrane cofactor protein genes on mouse cells inhibits lysis by human complement. Transplant Int 1992;5:648-650.
20. Cozzi E, Yannoutsos EC, Langford GA, et al. Effect of transgenic expression of human decay-accelerating factor on the inhibition of hyperacute rejection of pig organs. In: Cooper DKC, Kemp E, Platt JL, and White DJ, eds. Xenotransplantation. The Transplantation of Organs and Tissues Between Species, 2nd ed., Heidelberg: Verlag; 1997: 665-682.
21. McCurry KR, Kooyman DL, Alvarado CG, et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med 1995;1:423-427.
22. Bach FH, Winkler H, Ferran C, et al. Delayed xenograft rejection. Immunol Today 1996;17:379-384.
23. Galili U, Minanov OP, Michler RE, and Stone KR. High affinity anti-Gal IgG in chronic rejection in xenografts. Xenotransplantation 1997;4:127-131.
24. Osman N, McKenzie IFC, Ostenried K, et al. Combined transgenic expression of α-galactosidase and α-1,2-fucosyltransferase leads to optimal reduction in the major xenoepitope Gal-α (1,3) GAL. PNAS 1997; 94:14677-14682.
25. Sharma A, Okabe J, Birch P, et al. Reduction in the level of Gal (α1, 3) Gal in transgenic mice and pigs by the expression of an α(1, 2)fucosyltransferase. Proc Natl Acad Sci USA 1996;93: 7190-7195.
26. Parker P, Saadi S, Lin SS, et al. Transplantation of discordant xenografts: a challenge revisited. Immunol Today 1996;17:373-378.
27. Platt JL. Xenotransplantation: recent progress and current perspectives. Curr Opin Immunol 1996;8:721-728.
28. Zinkernagel RM, Ehl S, Aichele P, et al. Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity. Immunol Rev 1997;156: 199-209.
29. Doherty PC, and Zinkernagel RM. A biological role for the major histocompatibility antigens. Lancet 1975;i:1406-1409.
30. Landmarks. Genetic control of the antibody response in inbred mice. J NIH Res 1997;9:43-50.
31. Starzl TE, Marchioro TL, and Waddell WR. The reversal of rejection in human renal homografts with subsequent development of homograft tolerance. Surg Gynecol Obstet 1963;117:385-395.
32. Starzl TE, Demetris AJ, Murase N, et al. Cell migration, chimerism, and graft acceptance. Lancet 1992;339:1579-1582.
33. Starzl TE, Demetris AJ, Trucco M, et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 1993;17:1127-1152.
34. Starzl TE, Demetris AJ, Murase N, et al. The lost chord: microchimerism. Immunol Today 1996;17:577-584.